NAGI BIOSCIENCE SECURES 12.4M CHF INVESTMENT WITH AN OVERSUBSCRIBED SERIES A FUNDING ROUND

Saint-Sulpice, Switzerland Nagi Bioscience, a Swiss life sciences company developing next-generation laboratory equipment to unlock the full potential of alternatives to animal testing, is thrilled to announce the successful closure of its Series A funding round. The company has secured an oversubscribed 12.4M CHF investment from top-tier venture capital firms across Europe, co-led by Swisscanto and imec.xpand, together [...]

Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS

Kusatsu/Shiga, Japan - Takara Bio Inc. announces that it has entered into a License Agreement with non-profit/charity organization, Fondazione Telethon ETS (“Telethon”) (https://www.telethon.it/en), Italy, under which Takara Bio grants Telethon a commercial license to use RetroNectin®. Under this agreement, Takara Bio provides Telethon with reliable supplies of RetroNectin®.The technologies licensed to Telethon are based on [...]

LGC Group appoints David King as Non-Executive Director and Chairman

Today, LGC announced the appointment of David P. King as Non-Executive Chairman of its Board of Directors. Euan O’Sullivan, President & Chief Executive Officer (CEO) of LGC said: "We are delighted to welcome David to LGC’s Board of Directors, given his extensive healthcare experience within the diagnostics, pharmaceutical and biotech sectors, key customer focus areas [...]

QIAGEN extends AI capabilities of its NGS interpretation software QCI Interpret to enable clinical exome completeness

AI-driven literature extraction for thousands of rare disease genes fortifies and extends QIAGEN’s proprietary, human-certified content, providing complete bibliographic coverage of the clinical exome Enhanced AI-trained phenotype driven ranking of pathogenic variants improves accuracy and efficiency of prioritizing candidate variants New features reduce time needed for prioritization, assessment and interpretation of clinically relevant variants and [...]

Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS

New Kit expands suite of NGS Library Prep solutions on the BioXp® System Enabling Speed and Efficiency for Whole genome sequencing (WGS) applications with the Automated Molecular Biology Workstation SAN DIEGO -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp® NGS [...]

DNAnexus-enabled UK Biobank Research Analysis Platform Surpasses 5,000 Users in Two Years

World’s largest biomedical research resource now features more than 28 PB of data to help accelerate scientific discovery and improve human health MOUNTAIN VIEW, Calif.--DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced that the DNAnexus-enabled UK Biobank Research Analysis Platform (UKB-RAP) community has grown to more than [...]

Battery Ventures Creates Latest Lab-Automation Technologies Platform with Investments in Skalar Analytical, PromoChrom and LCTech

Investments set foundation for global platform of laboratory-automation technologies serving environmental, agricultural and food-and-beverage applications BOSTON--Battery Ventures, a global, technology-focused investment firm, today announced the creation of a new laboratory-automation platform following recent acquisitions of three complementary companies: Skalar Analytical, PromoChrom Technologies and LCTech. Skalar Analytical, based in Breda, the Netherlands, manufactures a range of [...]

BioFlyte Successfully Validates Aerosolized Fentanyl Detection Capabilities

Following in-house and third-party validation testing, BioFlyte adds aerosolized fentanyl to its classification library and becomes only market solution proven to simultaneously sample for both chemical and biological threat agents ALBUQUERQUE, N.M. — BioFlyte, a bioaerosol surveillance firm with a disruptive new class of fieldable biological threat collection, detection, and identification solutions, today announced that it [...]

Sartorius forms partnership with SPARTA Biodiscovery on novel nanoparticle analysis platform

SPARTA technology to accelerate the development, manufacture and quality control of nanoparticles used for gene therapies, vaccines, and cancer drugs Sartorius enters into minority shareholding GÖTTINGEN, Germany -- The life science group Sartorius and UK-based startup SPARTA Biodiscovery have agreed to partner on SPARTA’s analysis platform, which helps speed up the development, manufacture, and quality control of nanoparticles for [...]

Bio-Rad Launches PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers

Superior thermal performance and enhanced usability for PCR applications, such as sequencing, cloning, and genotyping.   HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of its PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, designed to support PCR [...]

Access IBO on Knowledge Center